GM1 Pentasaccharide sodium salt is a semisynthetic form of Ganglioside GM1, a sialic acid-containing glycolipid. Ganglioside GM1 is a component of the cell plasma membrane known to modulate cell signal transduction. Ganglioside GM1 can be a useful marker of cell types and antigens. It has been reported to spontaneously form small homogeneous vesicles without any protein templating. In response to ganglioside GM1, it has been reported that T cells from Guillain-Barrε syndrome patients produce interferon-gamma, a cytokine that is critical for the formation of adaptive immunity against bacterial or viral infections.
1. Schengrund, C.L. and Ringler, N.J. 1989. J. Biol. Chem. 264(22): 13233-13237. PMID: 2666416
2. Schroder, K. et al. 2004. J. Leukoc. Biol. 75(2): 163-189. PMID: 14525967
3. Chebukati, J.N. et al. 2010. Biochem. Biophys. Res. Commun. 394(3): 509-514. PMID: 20206128
4. McCombe, P.A. and Csurhes, P.A. 2010. J Clin Neurosci. 17(4): 537-538. PMID: 20093028
See how others have used GM1 Pentasaccharide sodium salt. Click on the entry to view the PubMed entry .
PMID: # 26735874 Shin, HH. et al. 2016. Biosens Bioelectron. 79: 398-405.
PMID: # 21949831 Bian, CF. et al. 2011. PLoS ONE. 6: e25007.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.